Navigation Links
The American Society for Aesthetic Plastic Surgery Addresses the Safety of Botox
Date:1/26/2008

NEW YORK, Jan. 26 /PRNewswire-USNewswire/ -- On January 23rd, Public Citizen, a consumer group, filed a petition with the U.S. Food and Drug and Administration (FDA) requesting labeling changes for botulinum toxins marketed in the United States.

Decades of use and recorded studies in peer-reviewed journals have documented the safety of BOTOX(R). The American Society for Aesthetic Plastic Surgery (ASAPS), the leading organization of board-certified plastic surgeons who specialize in cosmetic surgery of the face and body, emphasizes that Botox has been approved by the FDA as a Biologic Drug and, as with any medical treatment, patients should be fully informed as to the approved and off-label uses of the drug, as well as the benefits and risks of the procedure.

Since its FDA-approval for multiple neurological uses in 1989, Botox has been used millions of times. Widely tested over two decades, Botox has an excellent safety record. On April 15, 2002, the U.S. Food and Drug Administration (FDA) approved Botox for the treatment of moderate to severe glabellar frown lines (vertical creases between the brows). Other cosmetic uses of botulinum toxin continue to be off-label - that is, used at the physician's discretion with patient informed consent.

"As plastic surgeons committed to the safety and welfare of our patients, we have a great deal of interest and significant expertise informing patients about intended use of Botox and other aesthetic products," says Foad Nahai, MD, president of the American Society for Aesthetic Plastic Surgery (ASAPS). "We believe that the safety references in the petition are already satisfactorily addressed in the manufacturer labeling with detailed information and guidance, including approved indications, contraindications, warnings, drug interactions, precautions, and reported adverse event information. We believe that the product is safe and efficacious, and we recommend its continued use as indicated."

All procedures have the potential for adverse events and complications associated with them. It is important for physicians to have a proper medical history of patients prior to them receiving any treatment. Patients should be fully informed and educated about risks and benefits.

About ASAPS

The 2400-member American Society for Aesthetic Plastic Surgery (ASAPS) is the only plastic surgery organization devoted entirely to the advancement of cosmetic surgery. ASAPS is recognized throughout the world as the authoritative source for cosmetic surgery education. U.S. members are certified by the American Board of Plastic Surgery. Canadian members are certified in plastic surgery by the Royal College of Physicians and Surgeons of Canada. The Society receives educational grants from Industry.

Toll-free referral line: 888.ASAPS.11 (272.7711). Web site: http://www.surgery.org


'/>"/>
SOURCE The American Society for Aesthetic Plastic Surgery
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. American Society for Dermatologic Surgery Supports Current Labeling of Allergans Botox(R) Products
2. American Life League Praises Colorado Efforts to Stop Planned Parenthood Abortion Facility
3. Eating Healthy in the New Year? American Express Tastemakers Dish on the Top San Francisco Restaurants for Grabbing a Healthy Bite
4. United American Healthcare Corporation To Host Fiscal 2008 Second Quarter Results Conference Call Feb. 7
5. American Media, Inc. Names Dean Durbin Executive Vice President and Chief Financial Officer
6. American Life Leagues Training and Activism Event to be Streamed Live on Internet
7. American HealthChoice CEO Dr. J.W. Stucki Provides Company Update
8. American Academy of Ophthalmology Mourns Loss of Judah Folkman, MD, Pioneering Researcher
9. American Red Cross Partners With Safety4Kids(R) to Debut Childrens Fire Safety DVD
10. Black Americans Still Wary of Clinical Trials
11. Susan G. Komen for the Cures Circle of Promise and The Links, Incorporated Unite to Rewrite the Story on African Americans and Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology: